Assignee
ADARX PHARMACEUTICALS INC
US·2 granted patents·8 pending applications·0 citations·filing 2021–2024
Top patents by PatentIndex Score
10 records- 0162US2025073256A1Prekallikrein-modulating compositions and methods of use thereofADARX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0261US12042509B2Prekallikrein-modulating compositions and methods of use thereofADARX PHARMACEUTICALS INC·Filed 2022·Granted Jul 23, 2024·0 cites·36 claims
- 0361US2024041913A1Angiotensinogen-modulating compositions and methods of use thereofADARX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0459US2026000775A1a4ß1/7 INTEGRIN LIGAND CONJUGATED COMPOUNDS AND USES THEREOFADARX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0556US2025312367A1Oligonucleotides having a synthetic backbone and synthesis thereofADARX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0656US2025161459A1Trkb ligand conjugated compounds and uses thereofADARX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0754US2024401045A1Angiotensinogen-modulating compositions and methods of use thereofADARX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0850US12595477B2Complement Factor B-modulating compositions and methods of use thereofADARX PHARMACEUTICALS INC·Filed 2022·Granted Apr 7, 2026·0 cites·19 claims
- 0950US2024083934A1N-acetylgalactosamine (galnac)-derived compounds and oligonucleotidesADARX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1048US2024191229A1Rna silencing agents and methods of useADARX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ADARX PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →